Last reviewed · How we verify

NCT06596161

Iron Therpay and Fatigue in Women of Reprodcutive Age

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing Iron sucrose in Fatigue Syndrome, Chronic in 194 participants. Completed in 2 March 2024.

Timeline
25 February 2023
Primary endpoint
20 February 2024
2 March 2024

Quick facts

Lead sponsorCentral Park Medical College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment194
Start date25 February 2023
Primary completion20 February 2024
Estimated completion2 March 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Central Park Medical College

Who can join

Adults 18 to 45, female only, with Fatigue Syndrome, Chronic or Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

For the assessment of anemia and then assessment of fatigue levels in non-anemic women followed by assessment of iron levels and intervention of iron and placebo

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Iron sucrose

Trials testing the same drug.

Other recruiting trials for Fatigue Syndrome, Chronic

Currently open trials in the same condition.

Other Central Park Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06596161.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing